FRANKFORT, Ky. (WTVQ) – Kentucky’s Medicaid program is receiving around $5 million from a settlement with nation’s largest kidney dialysis provider.
The settlement resolves claims that Fresenius Medical Care Holdings Inc. violated Medicaid guidelines by failing to warn Kentucky dialysis clinics and doctors from 2003-2012 that its kidney dialysis product, GranuFlo, could result in dangerously increased bicarbonate levels.
According to the Kentucky Office of the Attorney General, clinics and doctors needed to know the risks of increased bicarbonate levels from GranuFlo in order to properly treat patients and to not put them at harm.
Fresenius is the largest provider of kidney dialysis and renal care products, treatment and services in the nation, with more than 2,200 dialysis clinics nationwide, including more than 50 clinics in Kentucky.
Fresenius also sold GranuFlo to independent clinics in Kentucky.